CMS revises ambulatory payment classifications for transnasal endoscopy procedures
Click Here to Manage Email Alerts
The CMS has modified the ambulatory payment classification assignments for transnasal esophagogastroduodenoscopy procedures, EvoEndo announced in a press release.
Using information submitted based on the cost of EvoEndo Model LE Single-Use Gastroscope and its recent 510(k) FDA clearance, the CMS modified the ambulatory payment classification assignments for CPT codes 0652T for transnasal diagnostic esophagogastroduodenoscopy (EGD), 0653T for transnasal EGD with biopsy and 0654T for transnasal EGD with insertion of intraluminal tube or catheter.
“We thank CMS for its consideration,” Heather Underwood, CEO at EvoEndo, said in the release. “We look forward to sharing this new payment alignment with health care providers as they consider the clinical and financial value of unsedated transnasal endoscopy.”
As of July 1, 2023, CPT 0652T and 0653T will switch from level 1 to level 2 upper GI procedures, the release stated, and CPT 0654T will change from level 2 to level 3 upper GI procedures.
“Unsedated transnasal endoscopy with the EvoEndo Single-Use Endoscopy System is designed to reduce preparation and recovery time for upper endoscopy procedures and to eliminate potential risks associated with sedation,” Ali Mencin, MD, chief of pediatric gastroenterology, hepatology and nutrition at Columbia University Irving Medical Center, said in the release. “This is especially important for our pediatric patients in need of diagnostic endoscopy with eosinophilic gastrointestinal disorders.”
Read more about
Click Here to Manage Email Alerts